| 中文名稱:CDK12-IN-6 | 英文名稱:CDK12-IN-6 |
| CAS:2651196-71-1 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 產(chǎn)品類別: 抑制劑 | |
| 貨號: T001|T40289 |
| 名稱 | CDK12-IN-6 |
| 描述 | CDK12-IN-6, a pyrazolotriazine compound, is a powerful inhibitor of CDK12. Its inhibitory activity is significant with an IC50 value of 1.19 μM when tested at high ATP concentration (2 mM). Notably, CDK12-IN-6 does not exhibit any inhibitory effect on CDK2/Cyclin E (IC50 >20 μM) and CDK9/Cyclin T1 (IC50 >20 μM) when tested under the same high ATP conditions (2 mM) (WO2021116178A1). |
| 體外活性 | CDK12-IN-6 (Example 174) inhibits BRCA1 MRNA expression in MDA-MB-231 cells (IC 50 =0.872 nM) and has no effect on CAL-120 cells[1]. CDK12-IN-6 has antproliferative activity in MDA-MB-231 cells (IC 50 =2.19 nM) and CAL-120 cells (IC 50 =1 nM)[1]. CDK12-IN-6 has a inhibition IC 50 CDK12 high ATP to Degradation DC 50 CDK12 ratio of 1851[1]. |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 關(guān)鍵字 | CDK-12-IN-6 | CDK12IN6 | CDK12 IN 6 |
| 相關(guān)產(chǎn)品 | 2,4,6-Trihydroxybenzoic acid | Seliciclib | PF07104091 | 2-Chloropyrazine | Sodium Oxamate | Abemaciclib methanesulfonate | Ribociclib | Abemaciclib | Amantadine | (E)-β-Farnesene | Dinaciclib | Kojic acid |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 589.8595萬人民幣 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP5年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2026-07-21 | |
| ¥1280 |
湖北艾普蒂生物工程有限公司
|
2025-06-04 | ||
| 詢價 |
VIP5年
|
湖北威德利化學(xué)試劑有限公司
|
2026-04-28 |